Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.633372
Title: Developing methods to image non-flourescent anticancer cylinders in cancer cell lines
Author: Khan, Zahra
ISNI:       0000 0004 5366 1232
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2014
Availability of Full Text:
Access through EThOS:
Access through Institution:
Abstract:
In this thesis, biological and imaging studies have been carried out on a supramolecular helicate (iron cylinder) and indirect methods to image this non-fluorescent compound have been developed. The iron cylinder has been investigated as a quencher of nuclear Hoechst fluorescence in a range of cancer cell lines. Flow cytometry and epifluorescence data has shown quenching occurring in a concentration-dependent manner at both the population and cellular level. These results provide evidence for the cylinder being able to interact in close proximity to the DNA within 20 minutes of administration. Using luciferase-expressing breast cancer cells, the iron cylinder has been shown to directly affect light emission in a concentration-dependent manner, an inhibition that has not previously been investigated providing further opportunities for imaging by monitoring the inhibition of luminescent enzymes. Furthermore, iron cylinder has been shown to quench GFP fluorescence using fluorimetry and confocal microscopy providing novel possibilities supporting the imaging of non-fluorescent compounds indirectly through the use of fluorescent stains. This thesis has also pioneered the first in vivo research relating to the iron cylinder in the model organism, zebrafish, and findings indicate a large therapeutic window over which the cylinder can bring about its effects.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.633372  DOI: Not available
Keywords: RC0254 Neoplasms. Tumors. Oncology (including Cancer) ; TP Chemical technology
Share: